Neuberger Berman Group LLC Intercept Pharmaceuticals, Inc. Transaction History

Neuberger Berman Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	BUY	$57.36 - $124.1 $286,800 - $620,500	5,000 New	5,000 $620,000
Q3 2019 Nov 13, 2019	SELL	$58.69 - $80.46 $358,009 - $490,805	-6,100 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$77.77 - $120.68 $202,202 - $313,768	2,600 Added 74.29%	6,100 $485,000
Q1 2019 May 13, 2019	BUY	$91.83 - $120.68 $321,405 - $422,380	3,500 New	3,500 $392,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.